These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12560428)

  • 21. Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer Population.
    Kabat GC; Ginsberg M; Sparano JA; Rohan TE
    J Racial Ethn Health Disparities; 2017 Dec; 4(6):1181-1188. PubMed ID: 28004356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of blacks and whites after a cancer diagnosis.
    Bach PB; Schrag D; Brawley OW; Galaznik A; Yakren S; Begg CB
    JAMA; 2002 Apr; 287(16):2106-13. PubMed ID: 11966385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).
    Brouquet A; Bachet JB; Huguet F; Karoui M; Artru P; Sabbagh C; Lefèvre JH; Vernerey D; Mariette C; Vicaut E; Benoist S;
    BMC Cancer; 2020 May; 20(1):485. PubMed ID: 32471382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group.
    Chen VW; Fenoglio-Preiser CM; Wu XC; Coates RJ; Reynolds P; Wickerham DL; Andrews P; Hunter C; Stemmermann G; Jackson JS; Edwards BK
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1087-93. PubMed ID: 9419408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
    Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
    Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009.
    Loja MN; Brunson A; Li CS; Carson JG; White RH; Romano PS; Hedayati N
    Ann Vasc Surg; 2015 Jul; 29(5):950-9. PubMed ID: 25757991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care study from the national cancer data base.
    Esnaola NF; Stewart AK; Feig BW; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2008 Nov; 15(11):3036-47. PubMed ID: 18712449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity.
    Gomez SL; O'Malley CD; Stroup A; Shema SJ; Satariano WA
    BMC Cancer; 2007 Oct; 7():193. PubMed ID: 17939875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group.
    Hunter CP; Redmond CK; Chen VW; Austin DF; Greenberg RS; Correa P; Muss HB; Forman MR; Wesley MN; Blacklow RS
    J Natl Cancer Inst; 1993 Jul; 85(14):1129-37. PubMed ID: 8320742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer.
    Graham MV; Geitz LM; Byhardt R; Asbell S; Roach M; Urtasun RC; Curran WJ; Lattin P; Russell AH; Cox JD
    J Natl Cancer Inst; 1992 Nov; 84(22):1731-5. PubMed ID: 1331484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
    Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
    Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Postoperative radiochemotherapy of rectal carcinoma reduces the incidence of locoregional recurrences but does not improve the prognosis of patients--the results of a randomized study of the NSABP-R02. National Surgical Adjuvant Breast and Bowel Project Protocol].
    Fietkau R; Rödel C
    Strahlenther Onkol; 2000 Aug; 176(8):381-2. PubMed ID: 10987022
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
    Wapnir IL; Dignam JJ; Fisher B; Mamounas EP; Anderson SJ; Julian TB; Land SR; Margolese RG; Swain SM; Costantino JP; Wolmark N
    J Natl Cancer Inst; 2011 Mar; 103(6):478-88. PubMed ID: 21398619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer.
    Akerley WL; Moritz TE; Ryan LS; Henderson WG; Zacharski LR
    Arch Intern Med; 1993 Jul; 153(14):1681-8. PubMed ID: 8333805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival differences in breast cancer among racial/ethnic groups: a population-based study.
    Boyer-Chammard A; Taylor TH; Anton-Culver H
    Cancer Detect Prev; 1999; 23(6):463-73. PubMed ID: 10571656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Race and ethnicity and breast cancer outcomes in an underinsured population.
    Komenaka IK; Martinez ME; Pennington RE; Hsu CH; Clare SE; Thompson PA; Murphy C; Zork NM; Goulet RJ
    J Natl Cancer Inst; 2010 Aug; 102(15):1178-87. PubMed ID: 20574040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
    Carson P; Ziesche S; Johnson G; Cohn JN
    J Card Fail; 1999 Sep; 5(3):178-87. PubMed ID: 10496190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.